Simple variables predict survival after autologous transplantation: A single centre experience in 181 multiple myeloma patients

Neoplasma

Volumn 54, Issue 2, 2007, Pages 143-148

  Krejci, M ^a   Hajek, R ^a   Buchler, T ^a   Krivanova, A ^a   Svobodnik, A ^b   Pour, L ^a   Adam, Z ^a   Mayer, J ^a   Vorlicek, J ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Age; Autologous transplantation; Complete response; Multiple myeloma; Prognostic factors

Indexed keywords

M PROTEIN; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; MULTIPLE MYELOMA M PROTEINS; MULTIPLE MYELOMA M-PROTEINS; PARAPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; OVERALL SURVIVAL; PARAMETER; RETROSPECTIVE STUDY; TREATMENT RESPONSE; AUTOTRANSPLANTATION; BLOOD; CANCER STAGING; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REMISSION; RISK FACTOR; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; CREATININE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; KIDNEY DISEASES; MIDDLE AGED; MULTIPLE MYELOMA; MYELOMA PROTEINS; NEOPLASM STAGING; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 34347215910     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. BATAILLE R, HAROUSSEAU JL. Multiple Myeloma. N Engl J Med 1997; 336: 1657-1664
2. GREENLEE RT, MURRAY T, BOLDEN S, WINGO PA. Cancer statistics. CA Cancer J Clin 2000; 50: 7-33
3. ATTAL M, HARROUSSEAU JL, STOPA AM, SOTTO JJ, FUZIBET JG et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91-97
4. BARLOGIE B, JAGANNATH S, VESOLE DH, NAUCKE S, CHESON B et al. Superiority of tandem transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997; 89: 789-793
5. LENHOFF S, HJORTH M, HOLMBERG E, TURESSON I, WESTIN J et al. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study group. Blood 2000; 95: 7-11
6. CHILD JA, MORGAN GJ, DAVIES FE, OWEN RG, BELL SE et al. High-dose chemotherapy with hematopoietic stemcell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875-1883 (Pubitemid 36532313)
7. BARLOGIE B, JAGANNATH S, DESIKAN KR, MATTOX S, VESOLE D et al. Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999; 93: 55-65
8. SIEGEL DS, DESIKAN KR, MEHTA J, SINGHAL S, FASSAS A et al. Age is not a prognostic variable with autotransplants for multiple myeloma.Blood 1999; 93: 51-54
9. BJORKSTRAND B, SVENSSON H, GOLDSCHMIDT H, LJUNGMAN P, APPERLEY J et al. Alpha-interferon maintenance treatment is associated with improved survival after high-dose treatment and autologous stem cell transplantation in patients with multiple myeloma: a retrospective registry study from the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2001; 27: 511-515
10. BADROS A, BARLOGIE B, SIEGEL E, ROBERTS J, LANGMAID C et al. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol 2001; 114: 822-829 (Pubitemid 32953738)
11. FASSAS AB, VAN RHEE F, TRICOT D. Predicting longterm survival in multiple myeloma following autotransplants. Leuk Lymphoma 2003; 44: 749-758
12. GREIPP PR, SAN MIGUEL J, DURIE BG, CROWLEY JJ, BARLOGIE B et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420
13. DURIE B, SALMON S. A clinical staging system for multiple myeloma. Cancer 1975; 36: 842-854
14. FACON T, MENARD JF, MICHAUX JL, EULLER-ZIEGLER L, BERNARD JF et al. Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. Am J Hematol 1995; 48: 71-75
15. BLADE J, SAMSON D, REECE D, APPERLEY J, BJORKSTRAND B et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by highdose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. Br J Haematol 1998; 102: 1115-1123
16. CLAVIO M, CASCIARO S, GATTI AM, SPRIANO M, BONANNI F et al. Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients. Haematologica 1996; 81: 238-244 (Pubitemid 126506600)
17. RICCARDI A, MORA O, BRUGNATELLI S, TINELLI C, SPANEDDA R et al. Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomized protocol. Cooperative Group of Study and Treatment of Multiple Myeloma. Br J Cancer 1998; 77: 485-1191
18. MAJOLINO I, VIGNETTI M, MELONI G, VEGNA ML, SCIME R et al. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo. Haematologica 1999; 84: 844-852 (Pubitemid 29474376)
19. BJORKSTRAND B. European Group for Blood and Marrow Transplantation Registry studies in multiple myeloma. Semin Hematol 2001; 38: 219-225
20. SIROHI B, POWLES R, MEHTA J, RUDIN C, KULKARNI S et al. An elective single autograft with high-dose melphalan: single-center study of 451 patients. Bone Marrow Transplant 2005; 36: 19-24
21. TERPOS E, APPERLEY JF, SAMSON D, GILES C, CRAWLEY C et al. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Bone Marrow Transplant 2003; 31: 163-170
22. SAN MIGUEL JF, LAHUERTA JJ, GARCIA-SANZ R, ALEGRE A, BLADE J et al. Are myeloma patients with renal failure candidates for autologous stem cell transplantation? Hematol J 2000; 1: 28-36
23. KNUDSEN LM, NIELSEN B, GIMSING P, GEISLER P. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure. Eur J Haematol 2005; 75: 27-33 (Pubitemid 40873958)
24. VESOLE DH, TRICOT G, JAGANATH S, DESIKAN KR, SIEGEL D et al. Autotransplants in multiple myeloma: what have we learned? Blood 1996; 88: 838-847
25. ALEGRE A, DIAZ-MEDIAVILLA J, SAN-MIGUEL J, MARTINEZ R, GARCIA-LARANA J et al. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Espanol de Trasplante Hematopoyetico-GETH) and PETHEMA. Bone Marrow Transplant 1998; 21: 133-140 (Pubitemid 28044005)
26. BARLOGIE B, TRICOT G, RASMUSSEN E, ANAISSIE E, VAN RHEE F et al. Total therapy 2 without thalidomide: comparison with total therapy 1: role of intensified induction and post-transplant consolidation therapies. Blood 2006; 107: 2633-2638
27. O'SHEA D, GILES C, TERPOS E, PERZ J, POLITOU M et al. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.Bone Marrow Transplant 2006; 37: 731-737
28. ALEXANIAN R, WEBER D, DELASALLE K, HANDY B, CHAMPLIN R et al. Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant 2004; 34: 229-234 (Pubitemid 39136829)
29. ATTAL M, HAROUSSEAU JL, FACON T, GUILHOT F, DOYEN C et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003; 349: 2495-2502 (Pubitemid 38010075)
30. DURIE BGM, JACOBSON J, BARLOGIE B, CROWLEY J. Magnitude of response with myeloma frontline therapy does not predict outcome: importance of time to progression in Southwest Oncology Group chemotherapy trials. J Clin Oncol 2004; 22: 1857-1863
31. GOJO I, MEISENBERG B, GUO C, FASSAS A, MURTHY A et al. Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma. Bone Marrow Transplant 2006; 37: 65-72 (Pubitemid 43135317)